3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Large B-Cell, Diffuse
6
Multiple Myeloma
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Congenital Abnormalities
5
Sezary Syndrome
4
Neoplasms, Plasma Cell
4
Mycosis Fungoides
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Accelerated Phase
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Blast Crisis
4
Uterine Cervical Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Hairy Cell
3
Leukemia
3
Hodgkin Disease
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Dysplasia
2
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Stomach Neoplasms
2
Interventions
tremelimumab
1
peginterferon alfa-2b
1
Zoledronic Acid
1
Zidovudine
1
Whole-Body Irradiation
1
Valproic Acid
1
Tetradecanoylphorbol Acetate
1
Sodium Chloride
1
Selenium
1
Rosuvastatin Calcium
1
Rituximab
1
Ribavirin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Observation
1
Moxifloxacin
1
Morphine
1
Microarray Analysis
1
Methadone
1
Laser Therapy
1
Interferon alpha-2
1
Infliximab
1
Gene Expression Profiling
1
Gadolinium DTPA
1
Fluorodeoxyglucose F18
1
Flow Cytometry
1
Fentanyl
1
Colposcopy
1
Ciprofloxacin
1
Chromatography, High Pressure Liquid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Precancerous Conditions
×
Flow Cytometry
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled